Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H C Bucher

Showing results (31-40 of 82) with videos related to

Pageof 9
Sort By:
Journal of Evaluation in Clinical Practice|August 26, 1999
Systematic validation of disease models for pharmacoeconomic evaluations. Swiss HIV Cohort StudyP P Sendi, B A Craig, D Pfluger, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|March 30, 1999
Estimating AIDS-free survival in a severely immunosuppressed asymptomatic HIV-infected population in the era of antiretroviral triple combination therapy. Swiss HIV Cohort StudyP P Sendi, H C Bucher, B A Craig, et al.
BJU International|October 6, 1999
Treatment for human immunodeficiency virus with indinavir may cause relevant urological side-effects, effectively treatable by rehydrationB Hug, M Naef, H C Bucher, et al.
Praxis|February 20, 1999
[Quality aspects in internal medicine--from anamnesis to meta-analysis]M Battegay, B Martina, B Bucheli, et al.
JAMA|August 27, 1999
Users' guides to the medical literature: XIX. Applying clinical trial results. A. How to use an article measuring the effect of an intervention on surrogate end points. Evidence-Based Medicine Working GroupH C Bucher, G H Guyatt, D J Cook, et al.
Drug and Alcohol Dependence|July 27, 2001
Onset and pattern of substance use in intravenous drug users of an opiate maintenance programC Zinkernagel, M R Naef, H C Bucher, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|November 27, 2013
Antiretroviral therapy for initial human immunodeficiency virus/AIDS treatment: critical appraisal of the evidence from over 100 randomized trials and 400 systematic reviews and meta-analysesS Kanters, E J Mills, K Thorlund, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 31, 1999
Reduced infections with HIV and hepatitis A during a Swiss intravenous opiate maintenance programM R Naef, H C Bucher, P Erb, et al.
Journal of Clinical Pharmacy and Therapeutics|July 9, 2009
Prescribed medications and pharmacy interventions for acute respiratory tract infections in Swiss primary careK E Hersberger, A Botomino, R Sarkar, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|April 20, 2011
Factors associated with positive blood cultures in outpatients with suspected bacteremiaK Wildi, S Tschudin-Sutter, S Dell-Kuster, et al.
Pageof 9

Showing results (31-40 of 82) with videos related to

Sort By:
Pageof 9
Journal of Evaluation in Clinical Practice|August 26, 1999
Systematic validation of disease models for pharmacoeconomic evaluations. Swiss HIV Cohort StudyP P Sendi, B A Craig, D Pfluger, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|March 30, 1999
Estimating AIDS-free survival in a severely immunosuppressed asymptomatic HIV-infected population in the era of antiretroviral triple combination therapy. Swiss HIV Cohort StudyP P Sendi, H C Bucher, B A Craig, et al.
BJU International|October 6, 1999
Treatment for human immunodeficiency virus with indinavir may cause relevant urological side-effects, effectively treatable by rehydrationB Hug, M Naef, H C Bucher, et al.
Praxis|February 20, 1999
[Quality aspects in internal medicine--from anamnesis to meta-analysis]M Battegay, B Martina, B Bucheli, et al.
JAMA|August 27, 1999
Users' guides to the medical literature: XIX. Applying clinical trial results. A. How to use an article measuring the effect of an intervention on surrogate end points. Evidence-Based Medicine Working GroupH C Bucher, G H Guyatt, D J Cook, et al.
Drug and Alcohol Dependence|July 27, 2001
Onset and pattern of substance use in intravenous drug users of an opiate maintenance programC Zinkernagel, M R Naef, H C Bucher, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|November 27, 2013
Antiretroviral therapy for initial human immunodeficiency virus/AIDS treatment: critical appraisal of the evidence from over 100 randomized trials and 400 systematic reviews and meta-analysesS Kanters, E J Mills, K Thorlund, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 31, 1999
Reduced infections with HIV and hepatitis A during a Swiss intravenous opiate maintenance programM R Naef, H C Bucher, P Erb, et al.
Journal of Clinical Pharmacy and Therapeutics|July 9, 2009
Prescribed medications and pharmacy interventions for acute respiratory tract infections in Swiss primary careK E Hersberger, A Botomino, R Sarkar, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|April 20, 2011
Factors associated with positive blood cultures in outpatients with suspected bacteremiaK Wildi, S Tschudin-Sutter, S Dell-Kuster, et al.
Pageof 9